BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24037954)

  • 1. Methamphetamine-associated cardiomyopathy.
    Won S; Hong RA; Shohet RV; Seto TB; Parikh NI
    Clin Cardiol; 2013 Dec; 36(12):737-42. PubMed ID: 24037954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.
    Reddy PKV; Ng TMH; Oh EE; Moady G; Elkayam U
    J Am Heart Assoc; 2020 Jun; 9(11):e016704. PubMed ID: 32468897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-associated cardiomyopathy: an addiction medicine perspective.
    Somma V; Osekowski M; Paratz E; Bonomo Y
    Intern Med J; 2023 Jan; 53(1):21-26. PubMed ID: 36693638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy.
    Osekowski M; Trytell A; La Gerche A; Prior D; MacIsaac A; Paratz ED
    Am J Cardiovasc Drugs; 2022 Jul; 22(4):385-393. PubMed ID: 35157254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine-Associated Cardiomyopathy in Pregnancy: A Case Series.
    Pierce SL; Zantow EW; Phillips SD; Williams M
    Mayo Clin Proc; 2019 Mar; 94(3):551-554. PubMed ID: 30832798
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine--what primary care practitioners need to know.
    McAvoy BR
    J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
    [No Abstract]   [Full Text] [Related]  

  • 8. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).
    Jafari Giv M
    Cardiovasc Toxicol; 2017 Jan; 17(1):13-24. PubMed ID: 27663745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.
    Courtney KE; Ray LA
    Drug Alcohol Depend; 2014 Oct; 143():11-21. PubMed ID: 25176528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine and meth mouth: an overview.
    Williams N; Covington JS
    J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
    [No Abstract]   [Full Text] [Related]  

  • 13. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.
    Dickson SD; Thomas IC; Bhatia HS; Nishimura M; Mahmud E; Tu XM; Lin T; Adler E; Greenberg B; Alshawabkeh L
    J Am Heart Assoc; 2021 Aug; 10(16):e018370. PubMed ID: 34365802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine and HIV.
    HRSA Careaction; 2009 Jun; ():1-8. PubMed ID: 19731419
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden and management of crystal meth use.
    Buxton JA; Dove NA
    CMAJ; 2008 Jun; 178(12):1537-9. PubMed ID: 18519899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.